Reconsidering PCOS Etiology, Diagnosis, Clinical Subgroups, and Subgroup-Specific Treatments

    January 2024 in “ Endocrine and metabolic science ”
    Vittorio Unfer, Eleni Kandaraki, Lali Pkhaladze, Scott Roseff, Mónica H. Vazquez‐Levin, Antonio Simone Laganà, C. Shiao-Yng, Maria Isidora Margarita Yap‐Garcia, Nicholas D. E. Greene, Christophe O. Soulage, Arturo Bevilacqua, Salvatore Benvenga, Lorenzo Di Bari, Basilio Pintaudi, Artur Wdowiak, Cesare Aragona, Zdravko Kamenov, Marialuisa Appetecchia, Giuseppina Porcaro, Imelda Hernández Marín, Fabio Facchinetti, Tony Tak Yu Chiu, O.A. Pustotina Pustotina, Olga Papalou, Maurizio Nordio, Tonino Cantelmi, Pietro Cavalli, Ivana Vučenik, Rosario D’Anna, Vittorio Unfer, Simona Dinicola, Saghar Salehpour, Annarita Stringaro, M Oliva, М. Т. Тугушев, Nikos Prapas, Mariano Bizzarri, Maria Salomè Bezerra Espinola, Cherubino Di Lorenzo, Ali Cenk Özay, John E. Nestler
    Image of study
    TLDR Different types of PCOS need specific diagnosis methods and treatments.
    Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder affecting 10-13% of women of reproductive age, with four clinical subgroups (A, B, C, and D) identified. Subgroups A, B, and C are characterized by hyperandrogenism and metabolic irregularities such as insulin resistance, which affects around 75% of PCOS patients. Subgroup D lacks hyperandrogenic features and has a lower incidence of metabolic and endocrine issues, suggesting a solely ovarian pathogenesis. The document suggests that the current diagnostic criteria for PCOS should consider additional parameters such as insulin resistance and endometrial thickness. It also highlights the need for a more tailored therapeutic approach, especially for subgroup D, and calls for further research to refine diagnostic criteria and develop targeted treatments.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 97 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Bryan Johnson just dropped his anti hair loss formula

      in Treatment  339 upvotes 10 months ago
      Bryan Johnson shared his hair loss treatment, which mainly relies on minoxidil and finasteride. Some users are skeptical of his results, while others appreciate his efforts in anti-aging and hair loss research.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Related Research

    3 / 3 results